The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
CAS No.:1997319-84-2; SGC-SMARCA-BRDVIII. SGC-SMARCA-BRDVIII (CAS No.:1997319-84-2), a bromodomain inhibitor, is part of ChemShuttle’s screening compounds for chromatin remodeling studies. Our CRO chemical synthesis division offers analog libraries based on CAS No.:1997319-84-2. As a screening compound, it enables epigenetic target validation in SWI/SNF-deficient cancers. The CRO chemical synthesis team develops SGC-SMARCA-BRDVIII (CAS No.:1997319-84-2) derivatives with enhanced cellular permeability. This screening compound supports combination therapy approaches in synthetic lethality models. ChemShuttle’s CRO chemical synthesis services accelerate lead optimization for CAS No.:1997319-84-2-based candidates.